SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hougen Elizabeth L – ‘4’ for 8/31/22 re: Ionis Pharmaceuticals Inc.

On:  Thursday, 9/1/22, at 7:03pm ET   ·   For:  8/31/22   ·   As:  Officer   ·   Accession #:  874015-22-154   ·   File #:  0-19125

Previous ‘4’:  ‘4’ on 3/2/22 for 2/28/22   ·   Next:  ‘4’ on 1/5/23 for 1/3/23   ·   Latest:  ‘4’ on 2/2/24 for 2/1/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/01/22  Hougen Elizabeth L                4          Officer     1:4K   Ionis Pharmaceuticals Inc.        Ionis Pharmas Inc.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      5K 
                Securities by an Insider -- edgardoc.xml/3.6                     




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  8/31/22
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  874015
Issuer Name:  IONIS PHARMACEUTICALS INC
Issuer Trading Symbol:  IONS
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1074773
Owner Name:  HOUGEN ELIZABETH L
Reporting Owner Address:
Owner Street 1:  2855 GAZELLE COURT
Owner Street 2:
Owner City:  CARLSBAD
Owner State:  CA
Owner ZIP Code:  92010
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  Yes
Is Ten Percent Owner?  No
Is Other?  No
Officer Title:  EVP, Finance & CFO
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  8/31/22
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  J
Equity Swap Involved?  No
Footnote ID:  F1
Transaction Amounts:
Transaction Shares:
Value:  202
Transaction Price Per Share:
Value:  28.968
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  58,561
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1Reporting shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2022. These shares may not be sold until February 28, 2023.
Owner Signature:
Signature Name:  By: Patrick R. O'Neil, attorney-in-fact For: Elizabeth L. Hougen
Signature Date:  9/1/22


Top
Filing Submission 0000874015-22-000154   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 8:41:22.2am ET